clarithromycin has been researched along with Aortic Aneurysm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hiramine, S; Kibe, Y; Kimura, S; Matsumoto, Y; Murata, M; Nishida, R; Shimono, N; Shiose, A; Sonoda, H; Takayama, K; Toyoda, K; Yamasaki, S | 1 |
| Abe, T; Lee Fujimoto, K; Mutsuga, M; Narita, Y; Oshima, H; Tokuda, Y; Uchida, W; Usui, A; Yamawaki-Ogata, A | 1 |
| Dalman, RL | 1 |
3 other study(ies) available for clarithromycin and Aortic Aneurysm
| Article | Year |
|---|---|
A case of mediastinal abscess and infected aortic aneurysm caused by dissemination of Mycobacterium abscessus subsp. massiliense pulmonary disease.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Aortic Aneurysm; Clarithromycin; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm.
Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Cells, Cultured; Clarithromycin; Disease Models, Animal; Elastin; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Macrophages; Male; Matrix Metalloproteinases, Secreted; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Phosphorylation; Vascular Remodeling | 2018 |
Invited commentary.
Topics: Administration, Oral; Aortic Aneurysm; Clarithromycin; Disease Progression; Humans | 2018 |